- ADJUNCT ASSISTANT PROFESSOR Psychiatry
- Appointments by phone only.
ResearchDr. Soorya's research includes the evaluation and treatment of individuals with autism spectrum disorders. Dr. Soorya oversees the clinical assessment, staff training, community outreach, and collaborations with community agencies at the Seaver Center, a multidisciplinary autism research center at the Mount Sinai School of Medicine. She has received funding from Autism Speaks several studies to evaluate the behavioral and neuropsychological variables influencing treatment response in individuals with autism spectrum disorders (ASDs). Dr. Soorya's active research projects include a randomized clinical trial of social skills interventions for children with ASDs and the evaluation of descriptive functional assessments as outcome measures in medication trials for individuals with ASDs.
Soorya LV, Kiarashi J, Hollander E. Treating Interfering Repetitive and Compulsive Behaviors. Child and Adolescent Psychiatry Clinics 2008;.
Thurm A, Soorya LV, Wagner A. Evaluation and Testing. In: Hollander E, Anagnostou E, editors. Clinical Manual for Treatment of Autism. Arlington, VA, American Psychiatric Publishing, Inc.;.
Hollander E, Bartz J, Chaplin W, Phillips A, Sumner J, Soorya L, Anagnostou E, Wasserman S. Oxytocin increases retention of social cognition in autism. Biological Psychiatry61 2007; 61(4): 498-503.
Anagnostou E, Esposito K, Soorya L, Chaplin W, Wasserman S, Hollander E. Divalproex vs. Placebo Reduces Irritability associated with Fluoxetine administration in autism. Journal of Clinical Psychopharmacology 2006; 26(4): 444-446.
Wasserman S, Iyengar R, Chaplin WF, Watner D, Waldoks SE, Anagnostou E, Soorya L, Hollander E. Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study. Int Clin Psychopharmacol 2006; 21(6): 363-367.
Hollander E, Soorya LV, Wasserman S, Esposito K, Chaplin W, Anagnostou E. Divalproex sodium vs. placebo in the treatment of repetitive behaviors in autism spectrum disorder. International Journal of Neuropsychopharmacology 2005; 8(1).
Hollander E, Anagnostou E, Chaplin W, Esposito K, Haznedar MM, Licalzi E, Wasserman S, Soorya L, Buchsbaum M. Striatal volume on magnetic resonance imaging and repetitive behaviors in autism. Biol Psychiatry 2005; 58(3): 226-232.
Soorya LV, Arnstein LA, Gillis J, Romanczyk RG. An overview of imitation skills: Implications for practice. Behavior Analyst Today 2003; 4(2): 114-123.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Soorya did not report having any of the following types of financial relationships with industry during 2014 and/or 2015: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
E Level, Room 22
New York, NY 10029